Overview
Corporate Profile
Biosergen AB is a Swedish biopharmaceutical company headquartered in Solna, Sweden
Biosergen AB focuses exclusively on the development of the antifungal product BSG005. BSG005 is an innovative new antifungal for the treatment of life threatening invasive fungal disease.
Most Recent Presentation
Stock Information